Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies
L Munoz, JF Nomdedéu, O López, MJ Carnicer… - …, 2001 - haematologica.org
BACKGROUND AND OBJECTIVES: The hematopoietic system is controlled by growth
factors (cytokines) which can influence cell survival, proliferation, differentiation and …
factors (cytokines) which can influence cell survival, proliferation, differentiation and …
Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post …
M Pratcorona, S Brunet, J Nomdedéu… - Blood, The Journal …, 2013 - ashpublications.org
Risk associated to FLT3 internal tandem duplication (FLT3-ITD) in patients with acute
myeloid leukemia (AML) may depend on mutational burden and its interaction with other …
myeloid leukemia (AML) may depend on mutational burden and its interaction with other …
ClonoSEQ assay for the detection of lymphoid malignancies
A Monter, JF Nomdedéu - Expert Review of Molecular Diagnostics, 2019 - Taylor & Francis
Introduction: Immunoglobulin rearrangement studies by molecular methods are routinely
used to detect clonality and to follow up patients with lymphoid malignancies. The design of …
used to detect clonality and to follow up patients with lymphoid malignancies. The design of …
Autonomic, neuroendocrine, and immunological effects of ayahuasca: a comparative study with d-amphetamine
RG Dos Santos, M Valle, JC Bouso… - Journal of clinical …, 2011 - journals.lww.com
Ayahuasca is an Amazonian psychotropic plant tea combining the 5-HT 2A agonist N, N-
dimethyltryptamine (DMT) and monoamine oxidase-inhibiting β-carboline alkaloids that …
dimethyltryptamine (DMT) and monoamine oxidase-inhibiting β-carboline alkaloids that …
Pharmacology of ayahuasca administered in two repeated doses
RG Dos Santos, E Grasa, M Valle, MR Ballester… - …, 2012 - Springer
Abstract Rationale Ayahuasca is an Amazonian tea containing the natural psychedelic 5-HT
2A/2C/1A agonist N, N-dimethyltryptamine (DMT). It is used in ceremonial contexts for its …
2A/2C/1A agonist N, N-dimethyltryptamine (DMT). It is used in ceremonial contexts for its …
Gene Expression Profiling of Acute Myeloid Leukemia with Translocation t(8;16)(p11;p13) and MYST3-CREBBP Rearrangement Reveals a Distinctive Signature with a Specific …
…, N Villamor, D Costa, A Carrió, J Nomdedéu… - Cancer research, 2006 - AACR
Acute myeloid leukemia (AML) with translocation t (8; 16)(p11; p13) is an infrequent
leukemia subtype with characteristic clinicobiological features. This translocation leads to …
leukemia subtype with characteristic clinicobiological features. This translocation leads to …
[HTML][HTML] The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants
The inclusion of familial myeloid malignancies as a separate disease entity in the revised
WHO classification has renewed efforts to improve the recognition and management of this …
WHO classification has renewed efforts to improve the recognition and management of this …
[HTML][HTML] Bone marrow WT1 levels at diagnosis, post-induction and post-intensification in adult de novo AML
JF Nomdedéu, M Hoyos, M Carricondo, E Bussaglia… - Leukemia, 2013 - nature.com
We retrospectively assessed whether normalized bone marrow WT1 levels could be used
for risk stratification in a consecutive series of 584 acute myeloid leukemia (AML) patients. A …
for risk stratification in a consecutive series of 584 acute myeloid leukemia (AML) patients. A …
[HTML][HTML] A certified plasmid reference material for the standardisation of BCR–ABL1 mRNA quantification by real-time quantitative PCR
…, M Nagar, G Nickless, J Nomdedéu… - Leukemia, 2015 - nature.com
Serial quantification of BCR–ABL1 mRNA is an important therapeutic indicator in chronic
myeloid leukaemia, but there is a substantial variation in results reported by different …
myeloid leukaemia, but there is a substantial variation in results reported by different …
[PDF][PDF] Allogeneic Stem-Cell Transplantation May Overcome the Adverse Prognosis of Unmutated VH Gene in Patients With Chronic Lymphocytic Leukemia
…, J Esteve, R Martino, J Nomdedéu… - Journal of clinical …, 2005 - researchgate.net
Allogeneic Stem-Cell Transplantation May Overcome the Adverse Prognosis of Unmutated VH
Gene in Patients With Chronic Lymphocyti Page 1 Allogeneic Stem-Cell Transplantation May …
Gene in Patients With Chronic Lymphocyti Page 1 Allogeneic Stem-Cell Transplantation May …